Advertisement

Topics

Companies Related to "AKTX Announces Clinical Data Post Transplant Thrombotic Microangiopathies" [Most Relevant Company Matches] RSS

10:44 EDT 22nd March 2019 | BioPortfolio

Here are the most relevant search results for "AKTX Announces Clinical Data Post Transplant Thrombotic Microangiopathies" found in our extensive corporate database of over 50,000 company records.

Showing "AKTX Announces Clinical Data Post Transplant Thrombotic Microangiopathies" Companies 1–25 of 7,300+

Relevant

SangStat Medical Corporation

SangStat, The Transplant Company(R), is a specialty pharmaceutical company applying a disease management approach to improve the outcome of organ transplantation. The Company's devices, drugs and services form a family of products that address the needs of patients in each stage of transplant care from pre-transplant monitoring to lifetime post-transplant care. SangStat's product pipeline is a com...


Guidry & East

Welcome! Thank you for visiting Guidry & East's website. We offer expert consulting services to Transplant Centers to bring efficiency, improve financial results, and enhance quality patient care.Our consulting team has collectively over 150 years of Clinical Transplant experience and includes experienced Transplant Administrators who have been responsible for gross revenues of over $200 million. ...

Transplant Genomics Inc.

Transplant Genomics is a molecular diagnostics company committed to improving organ transplant outcomes. Working with the transplant community, TGI will bring vital advances in diagnosis and prediction of transplant status from bench to clinic, supporting clinicians with clear, actionable information to optimize immunosuppression therapy, enhance patient c...


XDx Inc

Founded in 2000, XDx is a molecular diagnostics company based in South San Francisco, Calif. Setting the stage for a new era in personalized medicine, XDx is one of the first companies to develop and commercialize practical applications built on insights from the Human Genome Project. The company has developed a proprietary new method for noninvasively monitoring the immune system by measuring gen...

XDx, Inc.

Based in Brisbane, California, XDx is a molecular diagnostics company focused on the discovery, development and commercialization of noninvasive gene expression-based tests for the monitoring of transplant rejection and autoimmune diseases. The company has developed a proprietary new method for noninvasively monitoring immune system activity by measuring g...

Transplant Connect

Transplant Connect is an innovative medical software firm that specializes in electronic medical record and clinical information systems for the organ, tissue and eye transplant field. It was founded in 2003, with the mission of improving and increasing transplantation through modern software and communications. The iTransplantSM Platform is a web-centr...

Velos Inc.

Velos is the trusted platform for clinical research and specialized medical records. Velos products are used by customers to manage all aspects of clinical research, and in medical specialties to manage distinctive, complex medical records. Velos delivers its products both for customer installation and as services on the Internet. Solutions from Velos include: Velos eResearch for clinical trial ma...

AdverseEvents Inc.

AdverseEvents, Inc. (AEI) is a California-based healthcare informatics company that improves patient safety and reduces systemic healthcare costs through the comprehensive analysis of post-marketing drug side effect data. Utilizing data-mining and analysis technology, through its proprietary RxSuite™ of analytics, AEI makes post-marketing drug safety ...

Verana Health

Innovation in healthcare is hindered by the time and cost of bringing new therapeutics and devices to market. Verana Health is building a cutting-edge platform for life science innovation that utilizes regulatory-grade specialty data sets. This platform initially utilizes real-world data from the world’s largest clinical database in ophthalmology, rep...

BioFortis, Inc.

BioFortis is a leading provider of biomedical informatics solutions. Our lead product, Labmatrix(TM), addresses research needs of the post-genomic era within several key application areas including translational research, biobanking, biomarker discovery and clinical research. Labmatrix(TM) is a web-based software application for the management and exploration of clinical, specimen and molecular as...

The Washington Post

The Washington Post provides award-winning news and understanding about the politics, policies, personalities and institutions that make Washington, D.C. the world's seat of power, and is a critical tool and information source for those who call Washington, D.C. home. In digital form, The Washington Post combines its world-class journalism with the latest ...

Sristek

Data is critical. And it should be managed right, especially, for clinical trials, which is a tedious and time consuming process. Even the most minute aspects demand proven expertise and innovation in order to generate the most accurate results and analysis. In such a scenario, why not get the expert brains to manage it for you. Get Sristek into your business.Sristek is the mindware for complete d...

ZM Company

ZM Company,an independent Clinical Research Organization (CRO), provides outsourced services in Pharmacovigilance and Medical Affairs: Medical Monitoring, Clinical Monitoring, Serious Adverse Event (SAE) Management, Medical Data Review & Coding, Medical Writing, Consulting & Training in Clinical Research. Our organization is a team of physicians with profound academic background and hands-on clin...

Cell Medica

Cell Medica is a clinical stage cellular therapeutics company engaged in the development and delivery of cellular immunotherapy treatment strategies for infectious disease and cancer. The Company’s lead clinical application, referred to as Virus-Specific Immune Reconstitution (VSIR), involves the transfer of donor-derived virus-specific T cells into a...

Magenta Therapeutics Inc.

Magenta Therapeutics is a biotechnology company developing therapeutics to revolutionize bone marrow transplant for patients with autoimmune diseases, blood cancers and genetic diseases. By creating a platform focused on critical areas of transplant medicine, Magenta Therapeutics is pioneering an integrated approach to extend the curative power of bone mar...

eClinical Solutions

eClinical Solutions, a division of Eliassen Group, takes a strategic approach to managing clinical trial data by combining data management with statistical programming, reporting and customized training solutions integrated with a clinical data repository to deliver a complete end-to-end data management solution. With experience across a wide range of ther...

AHRM Inc.

AHRM Inc. specializes in applied healthcare resource management for clinical trials, data management, post market surveillance, regulatory compliance and many other areas. Contact us today and let us help you with your needs.

Aranesp

Aranesp® (darbepoetin alfa) is indicated for the treatment of anemia associated with chronic renal failure (CRF), including patients on dialysis and patients not on dialysis, and for the treatment of anemia in patients with nonmyeloid malignancies where anemia is due to the effect of concomitantly administered chemotherapy.Important Product Safety InformationAranesp® is contraindicated in patien...

Methodist Health System

The Transplant Institute at Methodist Dallas Medical Center has performed more than 2,500 transplants since its founding in 1981. The Institute made medical history in 1992 when it performed the world's first successful simultaneous heart-kidney-pancreas transplant. Since that time, Methodist Dallas Medical Center Transplant Center has performed three of the world's five combined simultaneous hear...

Diagnostica & Analys Service AB

Haemophilia caused by Factor VIII - or Factor IX deficiency and von Willebrand disease have long been possible to diagnose, but with some difficulties for the latter. In the mid 1970's Antithrombin III (ATIII) was suspected of being an important cause of thrombosis as patients with this deficiency often suffered from thrombotic complications and had a poor prognosis with Disseminated Intravascular...

Ars Arthro AG

The autologous cartilage transplant CaReSâ„¢ - Cartilage Repair System - offered by ARS ARTHRO AG is a 3D mechanically stable transplant based on patientspecific autologous cartilage cellls and a unique patent pending collagen matrix.Based on the present state of art, the Ars Arthro transplant is the only product with all of the following characteristics: easily adaptable intraoperatively to f...

Bio Pharma Services, Inc.

Bio Pharma Services Inc. is a full-service Contract Research Organization (CRO) specializing in the conduct of Phase I/IIa clinical trials as well as Bioequivalence trials for international pharmaceutical companies worldwide. With clinical facilities in Columbia, Missouri and Toronto, Canada, Bio Pharma’s total bed capacity sits at 250 with an impress...

Clinical Data, Inc

Founded in 1972, Clinical Data, Inc. is a worldwide leader in providing comprehensive molecular and pharmacogenomics services as well as clinical diagnostics to improve patient care. The Company is organized under three worldwide divisions segmented by service offerings and varying client constituents: PGxHealth™, Cogenics™, Vital Diagnostics™.Clinical Data’s genetic test division, PGxHeal...

OTTR / Hemasoft

Since 1993, OTTR has provided transplant software solutions that improve the quality of patient care via workflow management to reduce operational costs. As the leading provider of solid organ transplant and cellular therapy patient tracking software, OTTR serves over 200 programs at more than 60 transplant centers in the U.S. and Canada, and also offers s...

SYMFO (USA) Inc.

Symfo is a fast-growing international organization that has developed straightforward and affordable electronic data collection technologies used in clinical trials, post-approval studies and consumer product studies.The Symfo Company was founded in 2000.


More From BioPortfolio on "AKTX Announces Clinical Data Post Transplant Thrombotic Microangiopathies"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks